603567 HeiLongJiang ZBD Pharmaceutical

Watchlist

Not Open Mar 4 15:00 CST

10.31BMarket Cap15.78P/E (TTM)

HeiLongJiang ZBD Pharmaceutical Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2021/FY	4.127B / 4.049B	--

DatePeriodRevenue/EstimateEarnings Call

--2021/FY4.127B / 4.049B--

Report for the third quarter of 2024 of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

Oct 29, 2024 12:00 ET

Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

Aug 26, 2024 12:00 ET

Summary of the 2024 semi-annual report of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.

Aug 26, 2024 12:00 ET

Heilongjiang ZBD Pharmaceutical Co., Ltd.'s Annual Report 2023 - Revised Edition Summary.

Aug 7, 2024 12:00 ET